Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Cancer Vaccine + Nivolumab + Ipilimumab for Pancreatic and Colorectal Cancer
Recruiting1 awardPhase 1
Baltimore, Maryland
This trial is testing a new cancer vaccine for patients with pancreatic or colorectal cancer who have not responded to other treatments. The vaccine will be given with two other drugs, nivolumab and ipilimumab.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.